Kenya’s National Quality Control Laboratory (NQCL) recently attained a top international accreditation, multi-million dollar laboratory equipment for testing the quality of medicines, a new laboratory information management system, and an upgraded website.
USP's CEO Dr. Ron Piervincenzi relays his experiences and lessons learned from the 68th World Health Assembly held in Geneva, Switzerland, which he recently attended as a private advisor to the U.S. delegation led by Secretary of Health and Human Services, Sylvia Burwell.
The 2015 USP Convention is over, but the theme of the meeting - 'Shoulder to Shoulder on the Path to Improve Global Health' - will continue to be echoed over the next five years. Indeed, many of those who attended didn't just make connections, they listened, engaged and sought collaborations that may truly make a world of difference.
Over and under dosing--especially of children--based upon the “teaspoon” dosing instruction, can prolong an illness, compound an existing ailment, and may lead to death. USP has joined a growing chorus of public health organizations and government agencies calling for an end to the teaspoon as a unit of medication dosage measurement.
Today, approximately 80% of all active pharmaceutical ingredients in medicines sold in the U.S. are manufactured in another part of the world. While manufacturers have to ensure the quality and consistency of ingredients that go into final pharmaceutical products, they must also employ measures for the proper control of unwanted impurities in drugs and drug ingredients.
Dr. V. Srini Srinivasan, Executive Vice President and Chief Science Officer, is retiring after 29 years at the United States Pharmacopeia, where he provided leadership for documentary standard setting activities for all of USP’s compendia while overseeing the organization’s global expansion to India, China and Brazil.
Just one week from now, hundreds of Delegates, representing USP’s Convention Member Organizations, will gather in Washington, DC to elect USP’s Board of Trustees and Council of Experts as well as to make important decisions that will inform USP’s direction over the next five years, the 2015-2020 Cycle.